RAPT Therapeutics Inc News - RAPT | ADVFN

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
RAPT Therapeutics Inc (RAPT)
RAPT Therapeutics Inc (RAPT) News

RAPT Therapeutics Inc (RAPT)

0.7905

-0.0106

(-1.32%)

Closed April 18 4:00PM

Delayed by 15 minutes

0.7899

-0.0006

(-0.08%)

After Hours: 7:56PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development

SOUTH SAN FRANCISCO, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

RAPT Therapeutics to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

SOUTH SAN FRANCISCO, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form S-3 - Registration statement under Securities Act of 1933

1
Next

Monksdream

Monksdream 3 months ago

tbonaces80

tbonaces80 4 months ago

Buy this. Smart money in.

tbonaces80

tbonaces80 4 months ago

Gonna breakout above $2.11. Hold for major move. Shares gobbled on this wedge

glenn1919

glenn1919 4 months ago

RAPT......................https://stockcharts.com/h-sc/ui?s=RAPT&p=W&b=5&g=0&id=p86431144783

tw0122

tw0122 4 months ago

tbonaces80

tbonaces80 4 months ago

Wainwright ups price to $10. This will be going parabolic

tbonaces80

tbonaces80 4 months ago

We go hard this week. Too many Capital firms bought in. Load the boat $6-$10 easy

tbonaces80

tbonaces80 4 months ago

This will hit $6 easily. Analysts know. Huge funding. Foully loaded.

PonkenPlonken

PonkenPlonken 4 months ago

@tbonaces80 @Princess17
What do you two think about this?
150 million pp says massively misunderstood story? 140mn historical volume too...

tbonaces80

tbonaces80 4 months ago

tbonaces80

tbonaces80 4 months ago

Princess17

Princess17 4 months ago

👍🏻 looks good

tbonaces80

tbonaces80 4 months ago

Upgrade. Wells. Yup

PonkenPlonken

PonkenPlonken 4 months ago

see chart and compare PP to market cap
must be massively misunderstood

also had a license agreement today
Regards

bigbux1

bigbux1 4 months ago

What am I missing? They just did a private placement of 100,000,000 shares of common stock at a purchase price of $0.85 per share and this soars past 1.50?

Mister Mr

Mister Mr 4 months ago

Keep pumping! Let's go!!!

glenn1919

glenn1919 4 months ago

rapt........................https://stockcharts.com/h-sc/ui?s=rapt&p=W&b=5&g=0&id=p86431144783

PonkenPlonken

PonkenPlonken 4 months ago

https://www.globenewswire.com/news-release/2024/12/23/3001133/0/en/RAPT-Therapeutics-Announces-150-Million-Private-Placement.html
wow!
market cap 30 million no discount

Invest-in-America

Invest-in-America 4 months ago

RAPT:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175569055

tw0122

tw0122 4 months ago

RAPT up 15% news and TRAW also up $13.77 + 150% TRAW up big

glenn1919

glenn1919 5 months ago

RAPT.........................https://stockcharts.com/h-sc/ui?s=RAPT&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 8 months ago

Monksdream

Monksdream 8 months ago

RAPT new 52 week low

Monksdream

Monksdream 8 months ago

RAPT new 52 low

Monksdream

Monksdream 9 months ago

Monksdream

Monksdream 11 months ago

RAPT new 52 week

Monksdream

Monksdream 11 months ago

tickersym

tickersym 1 year ago

Bargin prices!! Lets go!!

Stockexpertpro

Stockexpertpro 1 year ago

RAPT Only 1 Patient had a problem out of 350 people enrolled in the trial

https://finance.yahoo.com/news/1-fda-puts-hold-two-125809258.html Fire sale down here lots of upgrades out last weeK

StockLogistics

StockLogistics 3 years ago

Surprised that no gap fill occurred prior to results expected near September 12, showing major strength buoyed by estimates of 50.00:

“8:04a ET 5/23/2022 - Benzinga
RAPT Therapeutics Announces Initiation Of Phase 2b Trial Of RPT193 In Patients With Moderate-to-Severe Atopic Dermatitis

RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced it has initiated its 16-week randomized, double-blind, placebo-controlled Phase 2b clinical trial to further evaluate the efficacy and safety of RPT193 as monotherapy in patients with moderate-to-severe atopic dermatitis (AD).”

StockLogistics

StockLogistics 3 years ago

12.16 gap fill over the next 14.5 weeks

StockLogistics

StockLogistics 3 years ago

12.16 gap fill over the next 14.5 weeks

StockLogistics

StockLogistics 3 years ago

15 weeks to go

8:04a ET 5/23/2022 - Benzinga
RAPT Therapeutics Announces Initiation Of Phase 2b Trial Of RPT193 In Patients With Moderate-to-Severe Atopic Dermatitis

Countdown to potential billions in revenue.

StockLogistics

StockLogistics 3 years ago

A ton of insider buying last week

StockLogistics

StockLogistics 3 years ago

Positive sentiment about billions that could be made from Rapt’s drug and pipe financing, perfect storm brewing

Glider549

Glider549 4 years ago

It happens,,and more often than not doesn't.
That's why I'd trim, but leave some on the table.

weasel4339

weasel4339 4 years ago

It's way up after hours bud

Glider549

Glider549 4 years ago

Can't believe some of you did not take profits near the close.
Greed will kill ya.

pennyfinder

pennyfinder 4 years ago

weasel4339

weasel4339 4 years ago

I'll keep n eye out. Let me knoe if u hear something about the price

pennyfinder

pennyfinder 4 years ago

Supposed to be. There’s no price set on the offering. They just said they’re raising $125M, they could be raising at $50… who knows… but the history has always been lower than the closing price. We will have to wait and see.

weasel4339

weasel4339 4 years ago

This considered dilution?

pennyfinder

pennyfinder 4 years ago

LOL

https://investors.rapt.com/news-releases/news-release-details/rapt-therapeutics-announces-proposed-public-offering-common

make it happen

make it happen 4 years ago

Most def. Idk how these companies even give a PT like that. Happens way to often and retails get blindsided. I wouldn't even do that if had all the power too.

pennyfinder

pennyfinder 4 years ago

Offering AH or tomorrow pre

make it happen

make it happen 4 years ago

Negative 1,000% plus operating margins. Only Phase 1 still, A long way to go...

Large negative lose percentages across the board on margins.

Only $0.22 revenue per share

Cash flow will burn all money before end of year.

Profitability
Profit Margin 0.00%
Operating Margin (ttm) -1,064.70%

Management Effectiveness
Return on Assets (ttm) -27.62%
Return on Equity (ttm) -50.34%

Income Statement
Revenue (ttm) 5.33M
Revenue Per Share (ttm) 0.22
Quarterly Revenue Growth (yoy) 30.70%
Gross Profit (ttm) 5.04M
EBITDA -55.53M
Net Income Avi to Common (ttm) -56.27M
Diluted EPS (ttm) -2.29

Balance Sheet
Total Cash (mrq) 98.41M
Total Cash Per Share (mrq) 3.93
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 9.21
Book Value Per Share (mrq) 3.69

Cash Flow Statement
Operating Cash Flow (ttm) -45.66M
Levered Free Cash Flow (ttm) -23.3M

StockLogistics

StockLogistics 4 years ago

This stock reported legitimate results of its study and is a short squeeze candidate imo if Reddit wanted to wake up to it

Roadtojourney

Roadtojourney 5 years ago

Not even 6 months old and already offering??

crudeoil24

crudeoil24 5 years ago

RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It is developing selective small molecules designed to modulate the critical immune responses underlying these diseases. It has discovered and advanced two drug candidates FLX475 and RPT193, which is engaged in targeting C-C motif chemokine receptor 4 (CCR4). Its drug discovery and development engine has identified CCR4 as a drug target that potentially has broad applicability in oncology and inflammatory diseases. Its lead oncology drug candidate FLX475, is designed to selectively inhibit the migration of immunosuppressive regulatory Treg cells into tumors. Its RPT193 drug candidate, is designed to selectively inhibit the migration of type 2 T helper cells (Th2 cells), into allergically-inflamed tissues.

crudeoil24

crudeoil24 5 years ago

42.00 > hod.

RAPT

RAPT Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions